Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Yates

Showing results (351-360 of 370) with videos related to

Pageof 37
Sort By:
Metabolism: Clinical and Experimental|September 18, 2004
Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoterNigel J Pearce, Jonathan R S Arch, John C Clapham, et al.
The Medical Journal of Australia|March 18, 2016
Clinical practice guidelines for dementia in AustraliaKate Laver, Robert G Cumming, Suzanne M Dyer, et al.
Journal of Lipid Research|March 26, 2009
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouseElaine M Quinet, Michael D Basso, Anita R Halpern, et al.
Journal of Lipid Research|July 19, 2005
Synthetic LXR agonists increase LDL in CETP speciesPieter H E Groot, Nigel J Pearce, John W Yates, et al.
Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasmaPaul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
American Journal of Human Genetics|June 18, 2005
Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndromeD Beysen, J Raes, B P Leroy, et al.
Physical Review Letters|February 7, 2013
Collective structure in 94Zr and subshell effects in shape coexistenceA Chakraborty, E E Peters, B P Crider, et al.
Journal of Medicinal Chemistry|October 17, 2009
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucomaBryce A Harrison, N Andrew Whitlock, Michael V Voronkov, et al.
Human Molecular Genetics|July 23, 2013
Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degenerationMorad Ansari, Paul M McKeigue, Christine Skerka, et al.
Pageof 37

Showing results (351-360 of 370) with videos related to

Sort By:
Pageof 37
Metabolism: Clinical and Experimental|September 18, 2004
Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoterNigel J Pearce, Jonathan R S Arch, John C Clapham, et al.
The Medical Journal of Australia|March 18, 2016
Clinical practice guidelines for dementia in AustraliaKate Laver, Robert G Cumming, Suzanne M Dyer, et al.
Journal of Lipid Research|March 26, 2009
LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouseElaine M Quinet, Michael D Basso, Anita R Halpern, et al.
Journal of Lipid Research|July 19, 2005
Synthetic LXR agonists increase LDL in CETP speciesPieter H E Groot, Nigel J Pearce, John W Yates, et al.
Human Molecular Genetics|October 19, 2018
A proteasome-resistant fragment of NIK mediates oncogenic NF-κB signaling in schwannomasJeffrey R Gehlhausen, Eric Hawley, Benjamin Mark Wahle, et al.
Proteomics. Clinical Applications|December 8, 2010
Proteomic identification and early validation of complement 1 inhibitor and pigment epithelium-derived factor: Two novel biomarkers of Alzheimer's disease in human plasmaPaul Cutler, Emma L Akuffo, Wanda M Bodnar, et al.
American Journal of Human Genetics|June 18, 2005
Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndromeD Beysen, J Raes, B P Leroy, et al.
Physical Review Letters|February 7, 2013
Collective structure in 94Zr and subshell effects in shape coexistenceA Chakraborty, E E Peters, B P Crider, et al.
Journal of Medicinal Chemistry|October 17, 2009
Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucomaBryce A Harrison, N Andrew Whitlock, Michael V Voronkov, et al.
Human Molecular Genetics|July 23, 2013
Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degenerationMorad Ansari, Paul M McKeigue, Christine Skerka, et al.
Pageof 37